NanoVibronix Inc. Announces U.S. Patent for Real-Time Imaging Overlay Technology in Medical Navigation

Reuters09-04
<a href="https://laohu8.com/S/NAOV">NanoVibronix Inc</a>. Announces U.S. Patent for Real-Time Imaging Overlay Technology in Medical Navigation

NanoVibronix Inc. recently announced that the United States Patent and Trademark Office has granted U.S. Patent No. 12,402,953 B2 to its subsidiary, ENvue Medical Holdings LLC. The patent, titled "Insertion Device Positioning Guidance System and Method," covers technology that overlays electromagnetic navigation data onto real-time medical imaging such as X-ray, CT, ultrasound, and MRI. This advancement enhances precision and efficiency in feeding tube placement and opens possibilities for vascular navigation applications. The patent strengthens ENvue's position in the market by offering increased procedural confidence and improved hospital workflows.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NanoVibronix Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250904265027) on September 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment